Clinical outcome of patients experiencing central nervous system progression on first-line pertuzumab and trastuzumab for HER2-positive metastatic breast cancer in a real-life cohort.

Affiliation auteurs!!!! Error affiliation !!!!
TitreClinical outcome of patients experiencing central nervous system progression on first-line pertuzumab and trastuzumab for HER2-positive metastatic breast cancer in a real-life cohort.
Type de publicationJournal Article
Year of Publication2020
AuteursCollet L, Eberst L, Fraisse J, Debled M, Levy C, Mouret-Reynier M-A, Desmoulins I, Goncalves A, Campone M, Ferrero J-M, Brain E, Dieras V, Petit T, Simon G, Leheurteur M, Dalenc F, Vanlemmens L, Darlix A, Arnedos M, Bachelot T
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume38
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X